Aprea Therapeutics Reports Fourth Quarter and Full Year 2023

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Texas , United States , Sweden , University Of Pennsylvania , Pennsylvania , American , Timothy Yap , Eric Brown , Oren Gilad , Mike Moyer , Fiona Simpkins , Nadeem Mirza , Division Of Gynecology Oncology , American Association Of Cancer Research , Atrin Pharmaceuticals Inc , Securities Exchange , Center Evaluation , Exchange Commission , Nasdaq , Aprea Therapeutics Inc , Abramson Family Cancer Research Institute , University Of Texas Md Anderson Cancer Center , Chief Executive Officer , Business Updates , Potential Upcoming Key , American Association , Cancer Research , Investigational New Drug , Multi Center Evaluation , Solid Tumors , Key Opinion Leader , Synthetic Lethality , Key Opinion Leaders , Gynecology Oncology , Cancer Center , Senior Medical , Financial Results , Fourth Quarter , Atrin Pharmaceuticals , Securities Act , Securities Exchange Act , Financial Condition , Months Ended December , Ended December ,